IP Library Granted Patent US 10,634,681
Granted Patent B2
US 10,634,681 · App. 14/001,159 · Granted Apr 28, 2020

Method for measuring cardiac troponin

Inventor: Yoshikazu Okamura (Tokyo, JP)
Assignee: LSI MEDIENCE CORPORATION
G01N33/68G01N33/6887G01N2333/4712
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,634,681
App. No.
14/001,159
Granted
Apr 28, 2020
Kind
B2
Abstract

Disclosed are a method for immunologically measuring cardiac troponin in a biological sample, in which the formation of an immunological complex of cardiac troponin with an antibody specifically binding thereto is performed in the presence of a divalent cation at 4 mmol/L or more; and a kit for measuring cardiac troponin, comprising an antibody specifically binding to cardiac troponin, and a buffer containing a divalent cation at a high concentration. According to the method or the kit, a stable and highly-accurate measured value can be obtained without being affected by interfering substances in a specimen regardless of the type of specimen.

Claims (4)

1. A method for immunologically measuring cardiac troponin in a biological sample, said method comprising: forming an immunological complex of cardiac troponin with an antibody specifically binding thereto in the presence of a divalent cation during the formation of the immunological complex of cardiac troponin with the antibody, wherein when the divalent cation is a calcium ion, the formation is carried out in the presence of the calcium ion at a concentration higher than 10 mmol/L, or when the divalent cation is a magnesium ion, the formation is carried out in the presence of the magnesium ion at 13.3 mmol/L or more.

2. The method according to claim 1 , wherein the divalent cation is contained in a sample dilution solution and/or an antibody solution.

3. The method according to claim 1 , wherein a first antibody and a second antibody which specifically bind to cardiac troponin are brought into contact with the biological sample, and an immunological complex formed by an antigen-antibody reaction is measured.

4. The method according to claim 3 , wherein the first antibody and the second antibody recognize different epitopes.

Assignments (4)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
CHANGE OF NAME Recorded Feb 5, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 034916/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: OKAMURA, YOSHIKAZU
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 031124/0890 →
Priority Claims (1)
JP 2011-039625 · Feb 25, 2011 · national
Continuity (1)
Related Publication 20130330841A1 · Dec 12, 2013